Canurta Inc.
$29,081.00 CAD
≈ 5 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- September 25, 2023 – May 10, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q2-1010759
Published purpose
Characterizing cannflavins and chrysoeriol as candidate therapeutic agents against glioblastoma multiforme (GBM) cells and breast cancer metastasis. This project will offer a solid foundation to pursue cannflavins and chrysoeriol as legitimate lead compounds against GBM cells and breast cancer metastasis that exploit the deregulation of TrkB signalling to thrive.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions